Journal
NEUROREHABILITATION
Volume 43, Issue 3, Pages 347-353Publisher
IOS PRESS
DOI: 10.3233/NRE-182536
Keywords
Brain injury; sleep; medications; pharmacology; therapy
Categories
Ask authors/readers for more resources
Sleep-wake disturbances (SWD) are prevalent in the traumatic brain injury (TBI) population and may exacerbate related neurobehavioral impairments. As such, it is important to recognize and treat SWD early to allow for optimal cognitive recovery following a TBI. A number of medications are currently available for treatment of SWD. However, most research in this area has historically focused on neurologically intact populations. This article reviews key pharmacologic treatment principles and agents to consider for use in the treatment of TBI-related SWD. In addition, it highlights available research literature that has examined the use of sleep medications in this unique population.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available